| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 40 | 2022 | 3280 | 6.020 |
Why?
|
| Bone Marrow | 28 | 2022 | 2948 | 5.740 |
Why?
|
| Body Composition | 45 | 2023 | 2402 | 5.040 |
Why?
|
| Bone Density | 50 | 2023 | 3468 | 4.660 |
Why?
|
| Obesity | 51 | 2024 | 12746 | 2.940 |
Why?
|
| Tomography, X-Ray Computed | 65 | 2023 | 20130 | 2.900 |
Why?
|
| Anorexia Nervosa | 20 | 2022 | 1286 | 2.820 |
Why?
|
| Abdominal Fat | 8 | 2020 | 223 | 2.810 |
Why?
|
| Gastrectomy | 17 | 2024 | 663 | 2.770 |
Why?
|
| Radius | 10 | 2023 | 422 | 2.730 |
Why?
|
| Bone Neoplasms | 16 | 2023 | 2530 | 2.350 |
Why?
|
| Magnetic Resonance Imaging | 78 | 2023 | 35425 | 2.270 |
Why?
|
| Human Growth Hormone | 14 | 2022 | 683 | 2.220 |
Why?
|
| Bone and Bones | 17 | 2023 | 2576 | 2.170 |
Why?
|
| Adipose Tissue, Brown | 9 | 2019 | 756 | 2.100 |
Why?
|
| Absorptiometry, Photon | 28 | 2023 | 1725 | 2.080 |
Why?
|
| Arthrography | 7 | 2021 | 149 | 2.010 |
Why?
|
| Awards and Prizes | 3 | 2023 | 375 | 1.860 |
Why?
|
| Fluorodeoxyglucose F18 | 17 | 2021 | 2016 | 1.850 |
Why?
|
| Intra-Abdominal Fat | 11 | 2022 | 591 | 1.820 |
Why?
|
| Adiposity | 19 | 2021 | 1806 | 1.650 |
Why?
|
| Obesity, Morbid | 11 | 2024 | 1213 | 1.630 |
Why?
|
| Femoracetabular Impingement | 5 | 2021 | 189 | 1.630 |
Why?
|
| Premenopause | 11 | 2016 | 1033 | 1.590 |
Why?
|
| Lumbar Vertebrae | 19 | 2023 | 1848 | 1.570 |
Why?
|
| Joint Diseases | 7 | 2019 | 479 | 1.560 |
Why?
|
| Obesity, Abdominal | 6 | 2017 | 361 | 1.370 |
Why?
|
| Fasting | 6 | 2023 | 1592 | 1.330 |
Why?
|
| Femur | 14 | 2023 | 1297 | 1.310 |
Why?
|
| Fractures, Bone | 6 | 2023 | 1947 | 1.300 |
Why?
|
| Spinal Neoplasms | 4 | 2022 | 760 | 1.280 |
Why?
|
| Muscle, Skeletal | 15 | 2022 | 4925 | 1.280 |
Why?
|
| Radiology | 5 | 2023 | 2099 | 1.270 |
Why?
|
| Hip Joint | 8 | 2021 | 1002 | 1.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2016 | 3759 | 1.200 |
Why?
|
| Whole Body Imaging | 10 | 2020 | 280 | 1.190 |
Why?
|
| Neurofibromatosis 1 | 11 | 2022 | 570 | 1.140 |
Why?
|
| Young Adult | 83 | 2024 | 56429 | 1.140 |
Why?
|
| Sarcopenia | 2 | 2022 | 368 | 1.130 |
Why?
|
| Femur Neck | 2 | 2021 | 309 | 1.120 |
Why?
|
| Insulin-Like Growth Factor I | 16 | 2023 | 2016 | 1.110 |
Why?
|
| Cartilage Diseases | 5 | 2019 | 160 | 1.090 |
Why?
|
| Adult | 159 | 2024 | 214052 | 1.090 |
Why?
|
| Humans | 265 | 2024 | 744366 | 1.060 |
Why?
|
| Elbow Joint | 5 | 2022 | 357 | 1.050 |
Why?
|
| Ischium | 4 | 2014 | 26 | 1.050 |
Why?
|
| Female | 190 | 2024 | 380193 | 1.040 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2018 | 177 | 1.030 |
Why?
|
| Tibia | 12 | 2023 | 1077 | 1.020 |
Why?
|
| Bone Diseases | 2 | 2019 | 416 | 1.000 |
Why?
|
| Adolescent | 82 | 2024 | 85779 | 0.990 |
Why?
|
| Arthroscopy | 9 | 2017 | 926 | 0.990 |
Why?
|
| Wrist Injuries | 3 | 2023 | 208 | 0.970 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2022 | 73 | 0.940 |
Why?
|
| Bariatric Surgery | 5 | 2021 | 952 | 0.940 |
Why?
|
| Lipid Metabolism | 7 | 2018 | 1889 | 0.920 |
Why?
|
| Cumulative Trauma Disorders | 3 | 2019 | 147 | 0.910 |
Why?
|
| Overweight | 12 | 2023 | 2371 | 0.910 |
Why?
|
| Hip Injuries | 2 | 2014 | 80 | 0.900 |
Why?
|
| Hip | 3 | 2014 | 257 | 0.900 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 581 | 0.890 |
Why?
|
| Middle Aged | 121 | 2022 | 213390 | 0.870 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2022 | 1856 | 0.850 |
Why?
|
| Osteoporosis | 3 | 2021 | 1579 | 0.840 |
Why?
|
| Arthralgia | 5 | 2015 | 456 | 0.830 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2017 | 93 | 0.810 |
Why?
|
| Male | 139 | 2023 | 350115 | 0.800 |
Why?
|
| Muscular Diseases | 4 | 2018 | 555 | 0.790 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2019 | 1363 | 0.790 |
Why?
|
| Neurofibromatoses | 6 | 2018 | 299 | 0.780 |
Why?
|
| Diagnostic Imaging | 4 | 2023 | 3508 | 0.780 |
Why?
|
| Musculoskeletal System | 3 | 2019 | 175 | 0.770 |
Why?
|
| Gastric Bypass | 6 | 2024 | 812 | 0.770 |
Why?
|
| Insulin Resistance | 13 | 2023 | 3864 | 0.770 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 75 | 0.760 |
Why?
|
| Positron-Emission Tomography | 14 | 2021 | 6234 | 0.750 |
Why?
|
| Radiopharmaceuticals | 11 | 2021 | 2645 | 0.740 |
Why?
|
| Faculty | 1 | 2023 | 387 | 0.720 |
Why?
|
| Knee Joint | 5 | 2018 | 1680 | 0.720 |
Why?
|
| Chordoma | 3 | 2020 | 359 | 0.710 |
Why?
|
| Opportunistic Infections | 1 | 2023 | 389 | 0.700 |
Why?
|
| Tendon Injuries | 7 | 2019 | 313 | 0.690 |
Why?
|
| Tendons | 4 | 2022 | 548 | 0.690 |
Why?
|
| Liver | 8 | 2023 | 7475 | 0.690 |
Why?
|
| Multiple Myeloma | 5 | 2021 | 5181 | 0.690 |
Why?
|
| Sarcoma | 4 | 2019 | 1897 | 0.680 |
Why?
|
| Injections, Intra-Articular | 6 | 2022 | 278 | 0.670 |
Why?
|
| Lipids | 7 | 2022 | 3307 | 0.660 |
Why?
|
| Acromegaly | 2 | 2020 | 347 | 0.650 |
Why?
|
| Osteoarthritis, Hip | 4 | 2021 | 412 | 0.640 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2017 | 19 | 0.620 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 3 | 2018 | 76 | 0.620 |
Why?
|
| Gadolinium DTPA | 3 | 2020 | 836 | 0.620 |
Why?
|
| Sensitivity and Specificity | 25 | 2018 | 14723 | 0.620 |
Why?
|
| Lumbosacral Region | 2 | 2016 | 310 | 0.620 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 239 | 0.620 |
Why?
|
| Radiography, Interventional | 5 | 2019 | 1095 | 0.610 |
Why?
|
| Injections | 1 | 2020 | 840 | 0.600 |
Why?
|
| Retrospective Studies | 50 | 2024 | 77460 | 0.590 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 3326 | 0.580 |
Why?
|
| Spinal Fractures | 5 | 2020 | 696 | 0.580 |
Why?
|
| Rupture | 7 | 2022 | 433 | 0.580 |
Why?
|
| Synovial Cyst | 1 | 2016 | 35 | 0.570 |
Why?
|
| Neurofibroma, Plexiform | 3 | 2022 | 71 | 0.560 |
Why?
|
| Collateral Ligaments | 2 | 2010 | 34 | 0.560 |
Why?
|
| Anesthetics, Local | 3 | 2019 | 985 | 0.550 |
Why?
|
| Contrast Media | 11 | 2020 | 5300 | 0.550 |
Why?
|
| Aged | 66 | 2022 | 163288 | 0.540 |
Why?
|
| Psoas Muscles | 1 | 2016 | 71 | 0.530 |
Why?
|
| Growth Hormone | 3 | 2023 | 705 | 0.530 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2015 | 53 | 0.510 |
Why?
|
| Calcitonin | 1 | 2016 | 336 | 0.510 |
Why?
|
| Physicians, Women | 1 | 2021 | 486 | 0.510 |
Why?
|
| Zygapophyseal Joint | 1 | 2016 | 129 | 0.490 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 15160 | 0.490 |
Why?
|
| Patient Positioning | 1 | 2017 | 324 | 0.480 |
Why?
|
| Bone Remodeling | 2 | 2016 | 575 | 0.470 |
Why?
|
| Faculty, Medical | 4 | 2023 | 1181 | 0.460 |
Why?
|
| Shoulder Joint | 3 | 2017 | 695 | 0.460 |
Why?
|
| Physical Examination | 1 | 2019 | 1237 | 0.450 |
Why?
|
| Pericardium | 1 | 2018 | 667 | 0.450 |
Why?
|
| Cold Temperature | 3 | 2015 | 772 | 0.450 |
Why?
|
| Fluoroscopy | 4 | 2019 | 924 | 0.450 |
Why?
|
| Adipocytes | 2 | 2017 | 1185 | 0.440 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 231 | 0.440 |
Why?
|
| Pelvis | 1 | 2017 | 730 | 0.440 |
Why?
|
| Tomography, Emission-Computed | 3 | 2007 | 1144 | 0.440 |
Why?
|
| Nerve Sheath Neoplasms | 4 | 2022 | 191 | 0.430 |
Why?
|
| Mentors | 3 | 2023 | 631 | 0.430 |
Why?
|
| Femur Head | 3 | 2021 | 301 | 0.430 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2017 | 122 | 0.430 |
Why?
|
| Burnout, Professional | 1 | 2021 | 694 | 0.420 |
Why?
|
| Cartilage, Articular | 4 | 2005 | 1095 | 0.420 |
Why?
|
| Estrone | 2 | 2023 | 240 | 0.410 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1547 | 0.410 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2016 | 417 | 0.410 |
Why?
|
| Chondroma | 1 | 2012 | 58 | 0.410 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 1486 | 0.410 |
Why?
|
| Neurilemmoma | 5 | 2018 | 547 | 0.410 |
Why?
|
| Reproducibility of Results | 21 | 2016 | 19905 | 0.400 |
Why?
|
| Protons | 3 | 2015 | 1127 | 0.400 |
Why?
|
| Caregivers | 1 | 2023 | 2095 | 0.400 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2585 | 0.390 |
Why?
|
| Steroids | 1 | 2016 | 930 | 0.390 |
Why?
|
| Radiography | 7 | 2023 | 7023 | 0.390 |
Why?
|
| Methionine | 2 | 2018 | 590 | 0.390 |
Why?
|
| Abdomen | 1 | 2017 | 1118 | 0.390 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 176 | 0.380 |
Why?
|
| Neck | 2 | 2016 | 698 | 0.380 |
Why?
|
| Diagnosis, Differential | 14 | 2021 | 12961 | 0.370 |
Why?
|
| Neurofibromatosis 2 | 5 | 2016 | 380 | 0.370 |
Why?
|
| Adiponectin | 4 | 2015 | 1101 | 0.370 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1677 | 0.360 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 57776 | 0.360 |
Why?
|
| Amenorrhea | 3 | 2021 | 485 | 0.350 |
Why?
|
| Spine | 4 | 2023 | 1144 | 0.350 |
Why?
|
| Pain | 4 | 2019 | 4988 | 0.350 |
Why?
|
| Regression Analysis | 8 | 2016 | 6459 | 0.350 |
Why?
|
| Triglycerides | 4 | 2014 | 2453 | 0.350 |
Why?
|
| Acetabulum | 2 | 2021 | 525 | 0.340 |
Why?
|
| Prospective Studies | 19 | 2023 | 53290 | 0.340 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2021 | 9240 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 772 | 0.340 |
Why?
|
| Anthropometry | 3 | 2013 | 1350 | 0.340 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 140 | 0.340 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 370 | 0.330 |
Why?
|
| Subcutaneous Fat | 5 | 2016 | 391 | 0.330 |
Why?
|
| Oxytocin | 2 | 2023 | 394 | 0.330 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2009 | 213 | 0.330 |
Why?
|
| Progesterone | 1 | 2013 | 775 | 0.320 |
Why?
|
| Body Mass Index | 14 | 2022 | 12721 | 0.320 |
Why?
|
| Thoracic Vertebrae | 2 | 2016 | 608 | 0.320 |
Why?
|
| Tendinopathy | 3 | 2017 | 154 | 0.320 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2022 | 116 | 0.320 |
Why?
|
| Trabecular Meshwork | 1 | 2008 | 99 | 0.320 |
Why?
|
| Sacrum | 2 | 2023 | 288 | 0.310 |
Why?
|
| Estrogens | 3 | 2021 | 1566 | 0.310 |
Why?
|
| Arthritis, Infectious | 1 | 2012 | 367 | 0.310 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2007 | 67 | 0.310 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 25039 | 0.300 |
Why?
|
| Fibrosarcoma | 2 | 2023 | 348 | 0.300 |
Why?
|
| Extremities | 4 | 2018 | 866 | 0.290 |
Why?
|
| Case-Control Studies | 16 | 2020 | 21748 | 0.290 |
Why?
|
| Hominidae | 2 | 2018 | 74 | 0.290 |
Why?
|
| Sacroiliac Joint | 1 | 2006 | 62 | 0.280 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 248 | 0.280 |
Why?
|
| Knee Injuries | 4 | 2018 | 490 | 0.280 |
Why?
|
| Fractures, Compression | 1 | 2008 | 133 | 0.280 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2047 | 0.270 |
Why?
|
| Hormones | 3 | 2016 | 889 | 0.270 |
Why?
|
| Metformin | 1 | 2013 | 836 | 0.270 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 555 | 0.270 |
Why?
|
| Prognosis | 10 | 2023 | 29060 | 0.270 |
Why?
|
| Placebos | 3 | 2017 | 1676 | 0.270 |
Why?
|
| Arginine | 1 | 2009 | 944 | 0.260 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2010 | 450 | 0.260 |
Why?
|
| Neoplasms | 4 | 2019 | 21696 | 0.260 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2006 | 156 | 0.260 |
Why?
|
| Scoliosis | 1 | 2011 | 725 | 0.250 |
Why?
|
| Neurofibroma | 2 | 2022 | 106 | 0.250 |
Why?
|
| Fractures, Spontaneous | 2 | 2017 | 230 | 0.250 |
Why?
|
| Ligaments, Articular | 2 | 2019 | 299 | 0.250 |
Why?
|
| Longitudinal Studies | 7 | 2023 | 13991 | 0.240 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2647 | 0.240 |
Why?
|
| Sports | 1 | 2010 | 688 | 0.240 |
Why?
|
| Gene Fusion | 3 | 2021 | 371 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7282 | 0.230 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1401 | 0.230 |
Why?
|
| Range of Motion, Articular | 4 | 2023 | 1578 | 0.220 |
Why?
|
| Radiation Dosage | 4 | 2019 | 1928 | 0.220 |
Why?
|
| Hydrocortisone | 3 | 2023 | 1826 | 0.220 |
Why?
|
| Cortisone | 1 | 2023 | 89 | 0.220 |
Why?
|
| Nerve Compression Syndromes | 2 | 2015 | 160 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 11726 | 0.220 |
Why?
|
| Finite Element Analysis | 4 | 2019 | 431 | 0.220 |
Why?
|
| Fats | 2 | 2016 | 102 | 0.220 |
Why?
|
| Osteosarcoma | 3 | 2018 | 881 | 0.210 |
Why?
|
| Societies, Medical | 3 | 2019 | 3743 | 0.210 |
Why?
|
| Buttocks | 2 | 2020 | 110 | 0.210 |
Why?
|
| Foot | 2 | 2018 | 527 | 0.210 |
Why?
|
| Appetite | 2 | 2022 | 243 | 0.210 |
Why?
|
| Osteoblastoma | 1 | 2022 | 24 | 0.210 |
Why?
|
| Diaphyses | 2 | 2019 | 65 | 0.200 |
Why?
|
| Athletic Injuries | 2 | 2018 | 1154 | 0.200 |
Why?
|
| Prevalence | 8 | 2020 | 15221 | 0.200 |
Why?
|
| Testosterone | 5 | 2023 | 2419 | 0.200 |
Why?
|
| Weight Loss | 5 | 2023 | 2625 | 0.200 |
Why?
|
| Treatment Outcome | 17 | 2022 | 63107 | 0.200 |
Why?
|
| Glucose | 3 | 2023 | 4398 | 0.200 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11031 | 0.200 |
Why?
|
| Risk Assessment | 9 | 2018 | 23336 | 0.190 |
Why?
|
| Bone Cysts | 1 | 2021 | 47 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2017 | 1166 | 0.190 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 2 | 2012 | 138 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2015 | 7882 | 0.190 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 251 | 0.190 |
Why?
|
| Langerhans Cells | 1 | 2021 | 173 | 0.190 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2016 | 548 | 0.190 |
Why?
|
| Double-Blind Method | 6 | 2023 | 12025 | 0.190 |
Why?
|
| Risk Factors | 18 | 2022 | 72296 | 0.190 |
Why?
|
| Career Mobility | 1 | 2023 | 262 | 0.190 |
Why?
|
| Traction | 1 | 2021 | 106 | 0.190 |
Why?
|
| Child | 18 | 2023 | 77709 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 2873 | 0.190 |
Why?
|
| Torsion Abnormality | 1 | 2021 | 93 | 0.190 |
Why?
|
| Pituitary Neoplasms | 2 | 2020 | 1345 | 0.190 |
Why?
|
| Ghrelin | 1 | 2022 | 266 | 0.190 |
Why?
|
| Chondroblastoma | 1 | 2020 | 50 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2023 | 309 | 0.180 |
Why?
|
| Muscular Atrophy | 2 | 2020 | 347 | 0.180 |
Why?
|
| Tennis Elbow | 1 | 1999 | 18 | 0.180 |
Why?
|
| Hypertension | 2 | 2020 | 8479 | 0.180 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 1999 | 33 | 0.180 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2021 | 171 | 0.180 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2021 | 216 | 0.180 |
Why?
|
| Cell Dedifferentiation | 1 | 2020 | 135 | 0.170 |
Why?
|
| Receptors, Somatostatin | 1 | 2020 | 129 | 0.170 |
Why?
|
| Berlin | 1 | 2018 | 23 | 0.170 |
Why?
|
| Humerus | 1 | 2021 | 266 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 348 | 0.170 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 381 | 0.170 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 39052 | 0.170 |
Why?
|
| Synovitis | 1 | 2000 | 209 | 0.170 |
Why?
|
| Injections, Intralesional | 2 | 2016 | 276 | 0.170 |
Why?
|
| Calcaneus | 3 | 2018 | 138 | 0.170 |
Why?
|
| Tarsal Bones | 2 | 2018 | 65 | 0.160 |
Why?
|
| Boston | 7 | 2020 | 9312 | 0.160 |
Why?
|
| Fibula | 1 | 2021 | 269 | 0.160 |
Why?
|
| Diet, Protein-Restricted | 1 | 2018 | 71 | 0.160 |
Why?
|
| Sex Factors | 4 | 2018 | 10400 | 0.160 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2021 | 225 | 0.160 |
Why?
|
| Fractures, Stress | 1 | 2020 | 187 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 449 | 0.160 |
Why?
|
| Tumor Burden | 5 | 2018 | 1915 | 0.160 |
Why?
|
| Pandemics | 4 | 2022 | 8385 | 0.160 |
Why?
|
| Femur Head Necrosis | 1 | 2019 | 132 | 0.160 |
Why?
|
| Fossils | 1 | 2018 | 76 | 0.160 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 1999 | 122 | 0.160 |
Why?
|
| Neural Conduction | 1 | 1999 | 440 | 0.160 |
Why?
|
| Predictive Value of Tests | 8 | 2018 | 15078 | 0.160 |
Why?
|
| Ergolines | 1 | 2017 | 61 | 0.160 |
Why?
|
| Water | 2 | 2018 | 1395 | 0.160 |
Why?
|
| Endometrium | 1 | 2000 | 424 | 0.150 |
Why?
|
| Femoral Neoplasms | 1 | 2017 | 77 | 0.150 |
Why?
|
| Pectoralis Muscles | 1 | 2018 | 82 | 0.150 |
Why?
|
| Shoulder | 1 | 1999 | 299 | 0.150 |
Why?
|
| Muscles | 2 | 2014 | 1614 | 0.150 |
Why?
|
| Osteocalcin | 2 | 2017 | 273 | 0.150 |
Why?
|
| Pituitary Diseases | 2 | 2016 | 141 | 0.150 |
Why?
|
| Thorax | 1 | 2020 | 547 | 0.150 |
Why?
|
| Central Cord Syndrome | 1 | 2016 | 4 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2020 | 1842 | 0.150 |
Why?
|
| Research Personnel | 1 | 2022 | 573 | 0.140 |
Why?
|
| Baseball | 2 | 2008 | 90 | 0.140 |
Why?
|
| Disease Progression | 5 | 2021 | 13286 | 0.140 |
Why?
|
| Radiation Protection | 2 | 2017 | 419 | 0.140 |
Why?
|
| Leg | 3 | 2011 | 1116 | 0.140 |
Why?
|
| Spondylosis | 1 | 2017 | 81 | 0.140 |
Why?
|
| Lipodystrophy | 1 | 2017 | 147 | 0.140 |
Why?
|
| Social Behavior | 1 | 2023 | 1127 | 0.140 |
Why?
|
| Germany | 1 | 2018 | 862 | 0.140 |
Why?
|
| Brain | 2 | 2021 | 26388 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 212 | 0.140 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 294 | 0.140 |
Why?
|
| Receptors, GABA | 1 | 2018 | 287 | 0.140 |
Why?
|
| Observer Variation | 4 | 2015 | 2593 | 0.140 |
Why?
|
| Calcinosis | 2 | 2016 | 1499 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 424 | 0.140 |
Why?
|
| Receptors, Somatotropin | 1 | 2016 | 76 | 0.140 |
Why?
|
| Liposarcoma | 1 | 2019 | 333 | 0.130 |
Why?
|
| Sarcoma, Synovial | 1 | 2017 | 167 | 0.130 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2016 | 238 | 0.130 |
Why?
|
| Gene Expression | 2 | 2021 | 7798 | 0.130 |
Why?
|
| Tarsal Joints | 1 | 2015 | 33 | 0.130 |
Why?
|
| Food | 1 | 2021 | 772 | 0.130 |
Why?
|
| Skin Neoplasms | 4 | 2018 | 5692 | 0.130 |
Why?
|
| Somatostatin | 1 | 2017 | 459 | 0.130 |
Why?
|
| Peer Group | 1 | 2020 | 635 | 0.130 |
Why?
|
| Foot Joints | 1 | 2015 | 36 | 0.130 |
Why?
|
| New York | 1 | 2018 | 886 | 0.130 |
Why?
|
| Starvation | 1 | 2015 | 134 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 400 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 513 | 0.130 |
Why?
|
| Blood Glucose | 5 | 2017 | 6254 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 391 | 0.130 |
Why?
|
| Cell Size | 1 | 2017 | 643 | 0.130 |
Why?
|
| Cardiovascular System | 2 | 2013 | 831 | 0.130 |
Why?
|
| Biopsy | 5 | 2018 | 6755 | 0.130 |
Why?
|
| Cushing Syndrome | 1 | 2016 | 249 | 0.130 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1796 | 0.120 |
Why?
|
| Perception | 1 | 2021 | 1198 | 0.120 |
Why?
|
| Venous Insufficiency | 1 | 2016 | 103 | 0.120 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2014 | 136 | 0.120 |
Why?
|
| Pain Measurement | 5 | 2018 | 3420 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2021 | 4222 | 0.120 |
Why?
|
| Epithelioid Cells | 1 | 2014 | 71 | 0.120 |
Why?
|
| Electromyography | 1 | 1999 | 1379 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2023 | 2488 | 0.120 |
Why?
|
| Canada | 1 | 2019 | 2065 | 0.120 |
Why?
|
| Comorbidity | 5 | 2019 | 10388 | 0.120 |
Why?
|
| Anorexia | 1 | 2014 | 161 | 0.120 |
Why?
|
| Causality | 3 | 2016 | 1275 | 0.120 |
Why?
|
| Iliotibial Band Syndrome | 1 | 2013 | 5 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 1221 | 0.120 |
Why?
|
| C-Reactive Protein | 5 | 2015 | 3778 | 0.120 |
Why?
|
| Femoral Neuropathy | 1 | 2013 | 9 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7182 | 0.120 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 1788 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2018 | 401 | 0.110 |
Why?
|
| Procollagen | 1 | 2014 | 185 | 0.110 |
Why?
|
| Endocrine System | 1 | 2014 | 113 | 0.110 |
Why?
|
| Bursa, Synovial | 1 | 2013 | 24 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2017 | 711 | 0.110 |
Why?
|
| Tenosynovitis | 1 | 2013 | 57 | 0.110 |
Why?
|
| Cognition | 3 | 2016 | 6770 | 0.110 |
Why?
|
| Tongue | 1 | 2016 | 406 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1660 | 0.110 |
Why?
|
| Ulna | 1 | 2014 | 133 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2015 | 1462 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2018 | 764 | 0.110 |
Why?
|
| Ligaments | 1 | 2013 | 129 | 0.110 |
Why?
|
| Respiratory System | 1 | 2016 | 557 | 0.110 |
Why?
|
| Angiofibroma | 1 | 2013 | 68 | 0.110 |
Why?
|
| Sternoclavicular Joint | 1 | 2012 | 30 | 0.110 |
Why?
|
| Atrophy | 2 | 2015 | 1584 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2015 | 5077 | 0.110 |
Why?
|
| Prednisone | 1 | 2017 | 1574 | 0.110 |
Why?
|
| Outpatients | 1 | 2020 | 1487 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20824 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2020 | 849 | 0.110 |
Why?
|
| Glucagon | 1 | 2014 | 533 | 0.110 |
Why?
|
| Bursitis | 1 | 2013 | 83 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 3 | 2012 | 1081 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2022 | 2897 | 0.110 |
Why?
|
| Myositis Ossificans | 1 | 2013 | 79 | 0.110 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 374 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12356 | 0.100 |
Why?
|
| Estradiol | 3 | 2021 | 2020 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2012 | 259 | 0.100 |
Why?
|
| Visual Perception | 1 | 2021 | 1420 | 0.100 |
Why?
|
| Leadership | 1 | 2021 | 1357 | 0.100 |
Why?
|
| Wrist Joint | 1 | 2014 | 256 | 0.100 |
Why?
|
| Patella | 1 | 2013 | 320 | 0.100 |
Why?
|
| Time Factors | 6 | 2017 | 40075 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2014 | 302 | 0.100 |
Why?
|
| Military Personnel | 1 | 2020 | 1133 | 0.100 |
Why?
|
| Syndrome | 3 | 2018 | 3252 | 0.100 |
Why?
|
| Thermogenesis | 1 | 2015 | 434 | 0.100 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 2513 | 0.100 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 1813 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 1246 | 0.100 |
Why?
|
| ROC Curve | 3 | 2020 | 3528 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2760 | 0.090 |
Why?
|
| Edema | 1 | 2014 | 789 | 0.090 |
Why?
|
| Vitamin D | 3 | 2013 | 3224 | 0.090 |
Why?
|
| Mitochondria | 2 | 2013 | 3514 | 0.090 |
Why?
|
| Iodide Peroxidase | 1 | 2012 | 293 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 2012 | 494 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2214 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2000 | 2212 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2016 | 917 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Insulin | 5 | 2023 | 6582 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1373 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 574 | 0.090 |
Why?
|
| Anxiety | 2 | 2024 | 4293 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 878 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1405 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2018 | 2251 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2108 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2016 | 828 | 0.090 |
Why?
|
| Ankle Injuries | 1 | 2013 | 331 | 0.080 |
Why?
|
| Skinfold Thickness | 1 | 2008 | 162 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1312 | 0.080 |
Why?
|
| New England | 1 | 2012 | 1022 | 0.080 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2008 | 45 | 0.080 |
Why?
|
| Health Promotion | 1 | 2021 | 2205 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3611 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2011 | 256 | 0.080 |
Why?
|
| Metatarsalgia | 1 | 2008 | 3 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2022 | 15297 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 632 | 0.080 |
Why?
|
| Patellar Dislocation | 1 | 2009 | 64 | 0.080 |
Why?
|
| Thyrotropin | 1 | 2012 | 849 | 0.080 |
Why?
|
| Thyroxine | 1 | 2012 | 667 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2020 | 11366 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 244 | 0.080 |
Why?
|
| Wound Healing | 1 | 2018 | 2785 | 0.080 |
Why?
|
| Adenoma | 1 | 2018 | 2174 | 0.080 |
Why?
|
| Athletes | 1 | 2015 | 1093 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 4042 | 0.070 |
Why?
|
| Memory | 2 | 2016 | 2174 | 0.070 |
Why?
|
| Friction | 2 | 2018 | 59 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4026 | 0.070 |
Why?
|
| Metatarsal Bones | 1 | 2008 | 107 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2007 | 467 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2011 | 689 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2014 | 1299 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4253 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2213 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2014 | 955 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 239 | 0.070 |
Why?
|
| Rotation | 2 | 2023 | 523 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 2943 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1800 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4671 | 0.070 |
Why?
|
| Exercise | 2 | 2013 | 5615 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2943 | 0.070 |
Why?
|
| Neutrophils | 1 | 2017 | 3721 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1953 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2355 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2021 | 1179 | 0.060 |
Why?
|
| Radiology Information Systems | 1 | 2009 | 523 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 5253 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3309 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5953 | 0.060 |
Why?
|
| Weight-Bearing | 2 | 2017 | 515 | 0.060 |
Why?
|
| Algorithms | 2 | 2017 | 13882 | 0.060 |
Why?
|
| Reference Values | 3 | 2017 | 4982 | 0.060 |
Why?
|
| Gonadal Hormones | 1 | 2023 | 29 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2016 | 1677 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 964 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2016 | 517 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.060 |
Why?
|
| Homeostasis | 2 | 2013 | 3339 | 0.060 |
Why?
|
| Ilium | 1 | 2023 | 154 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2011 | 1158 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2021 | 2649 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 130 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2014 | 8551 | 0.050 |
Why?
|
| Leucine | 1 | 2023 | 560 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2029 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2021 | 41005 | 0.050 |
Why?
|
| Joint Instability | 1 | 2009 | 792 | 0.050 |
Why?
|
| Periosteum | 1 | 2002 | 138 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5096 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 446 | 0.050 |
Why?
|
| Quality of Life | 3 | 2022 | 12802 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 7759 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7914 | 0.050 |
Why?
|
| Scapula | 1 | 2002 | 164 | 0.050 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2020 | 45 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6364 | 0.040 |
Why?
|
| Brachial Plexus Neuritis | 1 | 1999 | 20 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 390 | 0.040 |
Why?
|
| Executive Function | 2 | 2021 | 1364 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2001 | 298 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 1151 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2703 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 435 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 8949 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9584 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 21833 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3595 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2887 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 550 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5749 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2018 | 40559 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2002 | 973 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2000 | 507 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2021 | 12207 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2023 | 8319 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 381 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 141 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 495 | 0.030 |
Why?
|
| Phenotype | 3 | 2020 | 16367 | 0.030 |
Why?
|
| Animals | 9 | 2022 | 168768 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1588 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2018 | 254 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6598 | 0.030 |
Why?
|
| Iopamidol | 1 | 2016 | 191 | 0.030 |
Why?
|
| Cues | 1 | 2021 | 875 | 0.030 |
Why?
|
| Adrenal Gland Diseases | 1 | 2016 | 138 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 2018 | 268 | 0.030 |
Why?
|
| Laminectomy | 1 | 2016 | 234 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2016 | 5984 | 0.030 |
Why?
|
| Hallux | 1 | 2015 | 40 | 0.030 |
Why?
|
| Fracture Fixation | 1 | 2017 | 354 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 37 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 581 | 0.030 |
Why?
|
| Lipolysis | 1 | 2016 | 210 | 0.030 |
Why?
|
| Fracture Healing | 1 | 2017 | 427 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 44 | 0.030 |
Why?
|
| Sclerosis | 1 | 2014 | 213 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10637 | 0.030 |
Why?
|
| Incidence | 3 | 2022 | 20952 | 0.030 |
Why?
|
| Lipase | 1 | 2016 | 314 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 3001 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 730 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 547 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13104 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2012 | 27 | 0.030 |
Why?
|
| Leptin | 2 | 2012 | 1600 | 0.030 |
Why?
|
| Hematoma | 1 | 2018 | 758 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 810 | 0.030 |
Why?
|
| Cholesterol | 2 | 2015 | 2919 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13693 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 35134 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1115 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1276 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1862 | 0.030 |
Why?
|
| Back | 1 | 2012 | 66 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2016 | 729 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 620 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2917 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6621 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 351 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2418 | 0.020 |
Why?
|
| Equipment Design | 2 | 2011 | 3582 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2251 | 0.020 |
Why?
|
| Self Report | 1 | 2022 | 3553 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 428 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2727 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 885 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2015 | 670 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 721 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 976 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 569 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2949 | 0.020 |
Why?
|
| Histones | 1 | 2020 | 2598 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
| Anesthetics | 1 | 2015 | 539 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2023 | 6194 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2480 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2015 | 2879 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15535 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2012 | 451 | 0.020 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2008 | 32 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2016 | 1062 | 0.020 |
Why?
|
| Forefoot, Human | 1 | 2008 | 32 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2327 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 1094 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2015 | 1809 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 357 | 0.020 |
Why?
|
| E-Selectin | 1 | 2009 | 579 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2969 | 0.020 |
Why?
|
| Rotator Cuff | 1 | 2009 | 326 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5534 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 1337 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5856 | 0.020 |
Why?
|
| Mutation | 2 | 2020 | 29786 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12952 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4851 | 0.020 |
Why?
|
| Hyalin | 1 | 2005 | 37 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13409 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2009 | 1159 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 81201 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2019 | 7730 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8300 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 2736 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4441 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6994 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2016 | 5023 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16690 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2005 | 460 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 13035 | 0.010 |
Why?
|
| Shoulder Dislocation | 1 | 2002 | 122 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14561 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10483 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3203 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3658 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2921 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8664 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8662 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18373 | 0.010 |
Why?
|
| United States | 1 | 2016 | 69872 | 0.000 |
Why?
|